210 related articles for article (PubMed ID: 35434136)
21. Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.
Schwartz L; Spitsin SV; Meshki J; Tuluc F; Douglas SD; Wolfe JH
J Neurovirol; 2013 Jun; 19(3):219-27. PubMed ID: 23765222
[TBL] [Abstract][Full Text] [Related]
22. A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncRNA LOC389641.
Ji T; Ma K; Wu H; Cao T
J Immunol Res; 2022; 2022():5582811. PubMed ID: 35600049
[TBL] [Abstract][Full Text] [Related]
23. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R
Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857
[TBL] [Abstract][Full Text] [Related]
24. Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.
Borrego JF; Huelsmeyer MK; Pinkerton ME; Muszynski JL; Miller SA; Kurzman ID; Vail DM
Vet Comp Oncol; 2016 Jun; 14(2):210-24. PubMed ID: 24751104
[TBL] [Abstract][Full Text] [Related]
25. Substance P modulates colitis-associated fibrosis.
Koon HW; Shih D; Karagiannides I; Zhao D; Fazelbhoy Z; Hing T; Xu H; Lu B; Gerard N; Pothoulakis C
Am J Pathol; 2010 Nov; 177(5):2300-9. PubMed ID: 20889569
[TBL] [Abstract][Full Text] [Related]
26. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.
Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT
J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084
[TBL] [Abstract][Full Text] [Related]
27. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat.
McCarson KE; Krause JE; McLean S
Neurosci Lett; 1998 Jul; 251(2):113-6. PubMed ID: 9718987
[TBL] [Abstract][Full Text] [Related]
28. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala.
Khom S; Steinkellner T; Hnasko TS; Roberto M
Sci Adv; 2020 Mar; 6(12):eaaz1050. PubMed ID: 32206720
[TBL] [Abstract][Full Text] [Related]
29. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
[TBL] [Abstract][Full Text] [Related]
30. Diminished pheromone-induced sexual behavior in neurokinin-1 receptor deficient (TACR1(-/-)) mice.
Berger A; Tran AH; Dida J; Minkin S; Gerard NP; Yeomans J; Paige CJ
Genes Brain Behav; 2012 Jul; 11(5):568-76. PubMed ID: 22471406
[TBL] [Abstract][Full Text] [Related]
31. Advances in the research and application of neurokinin-1 receptor antagonists.
Hong X; Ma J; Zheng S; Zhao G; Fu C
J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494
[TBL] [Abstract][Full Text] [Related]
32. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
[TBL] [Abstract][Full Text] [Related]
33. Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action.
Karagiannides I; Stavrakis D; Bakirtzi K; Kokkotou E; Pirtskhalava T; Nayeb-Hashemi H; Bowe C; Bugni JM; Nuño M; Lu B; Gerard NP; Leeman SE; Kirkland JL; Pothoulakis C
Endocrinology; 2011 Jun; 152(6):2197-205. PubMed ID: 21467195
[TBL] [Abstract][Full Text] [Related]
34. Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours.
González Moles MA; Mosqueda-Taylor A; Esteban F; Gil-Montoya JA; Díaz-Franco MA; Delgado M; Muñoz M
Oral Oncol; 2008 Dec; 44(12):1127-33. PubMed ID: 18486533
[TBL] [Abstract][Full Text] [Related]
35. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with
Majkowska-Pilip A; Koźmiński P; Wawrzynowska A; Budlewski T; Kostkiewicz B; Gniazdowska E
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301182
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma.
Mehboob R; Kurdi M; Baeesa S; Fawzy Halawa T; Tanvir I; Maghrabi Y; Hakamy S; Saeedi R; Moshref R; Nasief H; Hassan A; Waseem H; Rasool S; Bahakeem B; Faizo E; Katib Y; Bamaga A; Aldardeir N
Folia Neuropathol; 2022; 60(2):165-176. PubMed ID: 35950469
[TBL] [Abstract][Full Text] [Related]
38. Substance P receptor expression in human skin keratinocytes and fibroblasts.
Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
[TBL] [Abstract][Full Text] [Related]
39. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.
Bremer AA; Leeman SE; Boyd ND
J Biol Chem; 2001 Jun; 276(25):22857-61. PubMed ID: 11294866
[TBL] [Abstract][Full Text] [Related]
40. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
